EUVIMEDEUVIMED entdecken
Leserbrief

What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?

Ruixuan Ai, Zhenyu Yang, Guanbang Hong, Yajun Wang iD

American Journal of Hematology · 2026-12 · 101 (12) · 3074-3076

DOI: 10.1002/ajh.70509 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 25.09.2026. Verfasst von Ruixuan Ai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shunde Women and Children's Hospital, Guangdong Medical University, Foshan, Guangdong, China. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

clinical trialseligibility criteriaineffective erythropoiesisnon‐transfusion‐dependent thalassemiatransfusion requirement

Autor:innen und Institutionen

  • Shunde Women and Children's Hospital, Guangdong Medical University, Foshan, Guangdong, China.
  • Xi'an Medical University, Xi'an, China.

ORCID-Profile: Yajun Wang

Zitieren

APA

Ai, R., Yang, Z., Hong, G., & Wang, Y. (2026). What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?. American Journal of Hematology, 101(12), 3074-3076. https://doi.org/10.1002/ajh.70509

Vancouver

Ai R, Yang Z, Hong G, Wang Y. What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?. American Journal of Hematology. 2026;101(12):3074-3076. doi:10.1002/ajh.70509

BibTeX
@article{Ai2026,
  author = {Ai, Ruixuan and Yang, Zhenyu and Hong, Guanbang and Wang, Yajun},
  title = {What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {12},
  pages = {3074--3076},
  doi = {10.1002/ajh.70509}
}
Kostenlos starten →